Formation of Azole-Resistant Candida albicans by Mutation of Sterol 14-Demethylase P450
Open Access
- 1 May 1999
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (5) , 1163-1169
- https://doi.org/10.1128/aac.43.5.1163
Abstract
The sterol 14-demethylase P450 (CYP51) of a fluconazole-resistant isolate of Candida albicans, DUMC136, showed reduced susceptibility to this azole but with little change in its catalytic activity. Twelve nucleotide substitutions, resulting in four amino acid changes, were identified in the DUMC136 CYP51 gene in comparison with a reported CYP51 sequence from a wild-type, fluconazole-susceptible C. albicans strain. Seven of these substitutions, including all of those causing amino acid changes, were located within a region covering one of the putative substrate recognition sites of the enzyme (SRS-1). Polymorphisms within this region were observed in several C. albicans isolates, and some were found to be CYP51 heterozygotes. Among the amino acid changes occurring in this region, only an alteration of Y132 was common among these fluconazole-resistant isolates, which suggests the importance of this residue to the fluconazole resistance of the target enzyme. DUMC136 and another fluconazole-resistant isolate were homozygotes with respect to CYP51, although the typical wild-type, fluconazole-susceptible C. albicans was aCYP51 heterozygote. These findings suggest that part of the fluconazole-resistant phenotype of C. albicans DUMC136 was acquired through a mutation-prone area of CYP51, an area which might promote the formation of fluconazole-resistant CYP51, along with a mechanism(s) which allows the formation of a homozygote of this altered CYP51 in this diploid pathogenic yeast.Keywords
This publication has 44 references indexed in Scilit:
- Resistance to fluconazole and cross‐resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol Δ5,6‐desaturationPublished by Wiley ,1998
- Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strainsFEMS Microbiology Letters, 1997
- The Mutation T315A in Candida albicans Sterol 14α-Demethylase Causes Reduced Enzyme Activity and Fluconazole Resistance through Reduced AffinityJournal of Biological Chemistry, 1997
- Detection and Significance of Fluconazole Resistance in Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1996
- Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transportersAntimicrobial Agents and Chemotherapy, 1995
- Candida albicans ALS1: domains related to a Saccharomyces cerevisiae sexual agglutinin separated by a repeating motifMolecular Microbiology, 1995
- Emergence of azole drug resistance in Candida species from HIV-infected patients receivingprolonged fluconazole therapy for oral candidosisJournal of Antimicrobial Chemotherapy, 1995
- Mode of action of the new quinolones: New dataEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Stereoselective interaction of an azole antifungal agent with its target, lanosterol 14α‐demethylase (cytochrome p‐45014dm): A model study with stereoisomers of triadimenol and purified cytochrome p‐45014dm from yeastChirality, 1990
- The Lipid Composition of Azole-sensitive and Azole-resistant Strains of Candida albicansMicrobiology, 1986